Van ECK Associates Corp Has $81,000 Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Van ECK Associates Corp decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 24.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,964 shares of the company’s stock after selling 626 shares during the period. Van ECK Associates Corp’s holdings in Doximity were worth $81,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Lmcg Investments LLC raised its holdings in Doximity by 5.3% during the third quarter. Lmcg Investments LLC now owns 152,435 shares of the company’s stock worth $6,642,000 after buying an additional 7,608 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Stephens Inc. AR purchased a new stake in shares of Doximity in the third quarter valued at about $257,000. New York State Teachers Retirement System raised its holdings in shares of Doximity by 4.7% in the third quarter. New York State Teachers Retirement System now owns 93,133 shares of the company’s stock valued at $4,058,000 after purchasing an additional 4,179 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in shares of Doximity in the third quarter valued at about $872,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Down 8.9 %

Shares of NASDAQ:DOCS opened at $52.88 on Thursday. The firm has a market capitalization of $9.82 billion, a PE ratio of 61.68, a P/E/G ratio of 5.08 and a beta of 1.30. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The company has a 50-day moving average price of $42.48 and a two-hundred day moving average price of $33.68.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DOCS. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and increased their target price for the company from $40.00 to $60.00 in a report on Wednesday. Bank of America increased their target price on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. KeyCorp upgraded shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price target for the company in a research report on Friday, November 8th. Finally, Canaccord Genuity Group restated a “hold” rating and set a $60.00 price target (up previously from $40.00) on shares of Doximity in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $48.14.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.